Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Recombinant LAG3 antibody

The Rat Monoclonal anti-LAG3 antibody is suitable to detect LAG3 in samples from Mouse. It has been validated for IP, FACS and BP.
Catalog No. ABIN7072736
-15% Promotion 2026
$601.80
$708.00
save $106.20 (-15 %)
Plus shipping costs $50.00
200 μg
Shipping to: United States
Delivery in 7 to 11 Business Days

Quick Overview for Recombinant LAG3 antibody (ABIN7072736)

Target

See all LAG3 Antibodies
LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

Antibody Type

Recombinant Antibody

Reactivity

  • 138
  • 35
  • 9
  • 4
  • 3
  • 2
  • 1
  • 1
  • 1
Mouse

Host

  • 66
  • 47
  • 25
  • 6
  • 4
  • 1
  • 1
Rat

Clonality

  • 94
  • 53
  • 2
Monoclonal

Conjugate

  • 79
  • 9
  • 8
  • 5
  • 5
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This LAG3 antibody is un-conjugated

Application

  • 73
  • 47
  • 43
  • 34
  • 28
  • 23
  • 15
  • 13
  • 13
  • 11
  • 9
  • 8
  • 5
  • 2
  • 2
  • 1
  • 1
Immunoprecipitation (IP), Flow Cytometry (FACS), Blocking Peptide (BP)

Clone

C9B7W
  • Purpose

    Anti-LAG-3 [C9B7W], Rat IgG1, kappa

    Specificity

    This antibody is specific for an epitope in the D2 domain of murine LAG-3.

    Characteristics

    Original Species of Ab: Rat

    Original Format of Ab: IgG1

    Purification

    Protein A affinity purified

    Immunogen

    This antibody was raised by immunising Lewis rats with a murine LAG-3:Ig fusion protein.

    Isotype

    IgG1 kappa
  • Application Notes

    This antibody has been used in flow cytometric analysis of splenocytes (Workman et al, 2005), T cell hybridomas expressing wild-type or chimeric CD4:murine LAG-3 (Workman et al, 2002) and CD4+ regulatory T cells (Chien et al, 2017). It has also been used in immunoprecipitation analysis of murine T hybridoma 3A9 cells transduced with murine LAG-3 (Li et al, 2004). This antibody blocks LAG-3 function in vitro, inhibiting antigen-induced IL-2 production in LAG-3-expressing T cell hybridomas, but does not block LAG-3:MHC class II interaction (Workman et al, 2002). Treatment with this antibody also blocks LAG-3 function in vivo, leading to accelerated homeostatic expansion of WT T cells (Workman et al, 2005). Administration of this LAG-3-blocking antibody, in combination with PD-L1 blockade, synergistically improves the survival of lymphodepleted myeloma-bearing mice (Jing et al, 2015).

    Restrictions

    For Research Use only
  • Concentration

    1 mg/mL

    Buffer

    PBS with 0.02 % Proclin 300.

    Preservative

    ProClin

    Precaution of Use

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C,-20 °C

    Storage Comment

    Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
  • Target

    LAG3 (Lymphocyte-Activation Gene 3 (LAG3))

    Alternative Name

    Lag3

    Background

    CD223, LAG3, Lymphocyte activation gene 3 protein

    UniProt

    Q61790

    Pathways

    Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints
You are here:
Chat with us!